Novartis buys MorphoSys for €2.7 billion to get cancer drugs

Novartis AG agreed to buy MorphoSys AG for €2.7 billion ($2.9 billion) as the Swiss pharma company starts following through on plans to use bolt-on…

Related Keywords

China ,Switzerland ,Swiss , ,Royal Health ,None King Charles Treated ,New Royal Health ,None Why ,Buildings Are ,Sale Now ,None China Tightens Some Trading Restrictions ,News ,Ggregator ,Reaking News ,Uration ,Media ,